Cargando…

Diabetes, SARS-CoV-2/COVID-19 vaccines and glycemic control: Call for data

Detalles Bibliográficos
Autor principal:	Ceriello, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932874/ https://www.ncbi.nlm.nih.gov/pubmed/33676994 http://dx.doi.org/10.1016/j.diabres.2021.108741

Ejemplares similares

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Effect of SARS-CoV-2 on glycemic control in post-COVID-19 diabetic patients
por: Yadaiah, Keerthi Bapanpally, et al.
Publicado: (2022)

Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjects
por: Greco, Carla, et al.
Publicado: (2023)

The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
por: Gentile, Sandro, et al.
Publicado: (2020)

Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes
por: Marfella, Raffaele, et al.
Publicado: (2022)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
por: Shang, Weilong, et al.
Publicado: (2020)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

Diabetes mellitus and SARS-CoV-2 infection()
por: Alonso, Núria, et al.
Publicado: (2021)

A vaccine for SARS-CoV-2: goals and promises
Publicado: (2020)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

SARS-CoV-2 Vaccination for Children—An Open Issue
por: Caselli, Désirée, et al.
Publicado: (2021)

Vaccination for SARS-CoV-2 of migrants and refugees, Jordan
por: Bellizzi, Saverio, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

SARS-CoV-2 vaccines for cancer patients: a call to action
por: Corti, Chiara, et al.
Publicado: (2021)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

Diabetes Research and Clinical Practice and the fight against COVID-19
por: Ceriello, Antonio
Publicado: (2022)

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
por: Kremer, Eric J.
Publicado: (2020)

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
por: Morris, Kevin V.
Publicado: (2020)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

Commentary on ‘Will vaccination refusal prolong the war on SARS-CoV-2?’
por: Welsby, Philip D
Publicado: (2020)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Focus on SARS-CoV-2 and COVID-19
por: Chen, Sharon C-A., et al.
Publicado: (2020)

SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs
por: Petersen, Eskild, et al.
Publicado: (2021)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
por: Kakulavarapu, Srividya, et al.
Publicado: (2021)

Can an effective SARS-CoV-2 vaccine be developed for the older population?
por: Pawelec, Graham, et al.
Publicado: (2020)

Realising the potential of SARS-CoV-2 vaccines—a long shot?
por: The Lancet Respiratory Medicine
Publicado: (2021)

SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention
por: Rubin, Eric J., et al.
Publicado: (2020)

Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
por: Krueger, Karen M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_roiop9r8kk8n27s94rqc1sj98k